The chairperson and consumer representative seats are vacant
::: : -1glucagon-like peptide-1 agonists, GLP-1 agonists-4dipeptidyl peptidase-4 inhibitors, DDP-4 inhibitors incretinGLP-1GLP-1GLP-1GLP-1GLP-1DDP-4 exenatide Byetta ,Bydureon ,liraglutide Victoza ,GLP-1Exendin-4Gila monsterGLP-1DDP-4Exenatideexendin-4metforminglitazoneExenatideByetta 5g66010Bydureon 2mgExenatideHbA1CexenatideexenatideLiraglutideGLP-10.61.2-1.8LiraglutideHbA1Cexenatideexenatideexenatide DDP-4GLP-1DDP-4sitagliptinJanuvia ,saxagliptinOnglyza ,linagliptinTrajenta ,vildagliptinGalvus ,4vildagliptinDDP-4HbA1CDDP-4 microvascular disease75162macrovascular disease -incretinDDP-4137-140
Proc R Soc Med
Figure 1 Figure 2 3 Mechanisms of action for GLP-1R agonists to control food intake GLP-1R agonists primarily act to reduce body weight by suppressing energy intake
To view a copy of this licence, visit About this article Cite this article Choudhury, A., Kirti, A., Lenka, S.S
Orient J Chem 30:12431251